{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:59:09Z","timestamp":1792277949814,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajo.2025.02.027","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:54:27Z","timestamp":1740509667000},"page":"42-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical Characteristics Associated With Complications and Poor Visual Outcomes in Ocular Toxoplasmosis: Analysis of 853 Patients"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0684-1989","authenticated-orcid":false,"given":"Alejandra","family":"de-la-Torre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Mej\u00eda-Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2703-0977","authenticated-orcid":false,"given":"Carlos","family":"Cifuentes-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8575-6576","authenticated-orcid":false,"given":"Miguel","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6198-0503","authenticated-orcid":false,"given":"Carlos M.","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Isabel","family":"Pach\u00f3n-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1790-8344","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Bustamante-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rojas-Carabali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2025.02.027_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2019.06.003","article-title":"Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis","volume":"227","author":"Zhang","year":"2019","journal-title":"Microbiol Res"},{"key":"10.1016\/j.ajo.2025.02.027_bib0002","first-page":"1","article-title":"Ocular toxoplasmosis","author":"Goh","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"10.1016\/j.ajo.2025.02.027_bib0003","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: global status of toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis","volume":"39","author":"Pappas","year":"2009","journal-title":"Int J Parasitol"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.027_bib0004","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.027_bib0005","first-page":"7","article-title":"Toxoplasmosis: un problema de Salud P\u00fablica en Colombia","volume":"4","author":"G\u00f3mez-Mar\u00edn","year":"2002","journal-title":"Rev Salud Publica"},{"issue":"12","key":"10.1016\/j.ajo.2025.02.027_bib0006","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1093\/infdis\/jiu833","article-title":"Striking divergence in toxoplasma ROP16 nucleotide sequences from Human and meat samples","volume":"211","author":"Alvarez","year":"2015","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.027_bib0007","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.parint.2013.10.012","article-title":"Characterization of ROP18 alleles in human toxoplasmosis","volume":"63","author":"S\u00e1nchez","year":"2014","journal-title":"Parasitol Int"},{"key":"10.1016\/j.ajo.2025.02.027_bib0008","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijid.2022.02.028","article-title":"Colombian Ocular Infectious Epidemiology Study (COIES): ocular toxoplasmosis incidence and sociodemographic characterization, 2015-2019","volume":"117","author":"Cifuentes-Gonz\u00e1lez","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1016\/j.ajo.2025.02.027_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010742","article-title":"Exploring the association between precipitation and population cases of ocular toxoplasmosis in Colombia","volume":"16","author":"Boada-Robayo","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.027_bib0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00417-022-05796-2","article-title":"A new look into uveitis in Colombia: changes in distribution patterns and clinical characteristics over the last 25 years","volume":"261","author":"Polan\u00eda","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2025.02.027_bib0011","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-024-06422-z","article-title":"Epidemiology, clinical features, and classification of 3,404 patients with uveitis: colombian Uveitis Multicenter Study (COL-UVEA)","author":"de-la-Torre","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2025.02.027_bib0012","doi-asserted-by":"crossref","DOI":"10.15649\/cuidarte.2036","article-title":"Etiolog\u00eda de baja visi\u00f3n y ceguera en siete centros de referencia en Colombia entre los a\u00f1os 2012 a 2017","author":"Su\u00e1rez Escudero","year":"2022","journal-title":"Rev Cuid"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.027_bib0013","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1038\/s41598-021-82830-z","article-title":"Clinical manifestations and visual outcomes associated with ocular toxoplasmosis in a Brazilian population","volume":"11","author":"Arruda","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.027_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283845","article-title":"Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: a systematic review and meta-analysis. Hwang DK","volume":"18","author":"Cifuentes-Gonz\u00e1lez","year":"2023","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.027_bib0015","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1177\/1120672119899379","article-title":"Risk factors for ocular complications in adult patients with uveitis","volume":"30","author":"Prieto-del-Cura","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.027_bib0016","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ajo.2008.09.006","article-title":"Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination","volume":"146","author":"Dodds","year":"2008","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.027_bib0017","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1523-5378.2011.00916.x","article-title":"Serologic evidence that Ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians","volume":"17","author":"Ek","year":"2012","journal-title":"Helicobacter"},{"issue":"11","key":"10.1016\/j.ajo.2025.02.027_bib0018","doi-asserted-by":"crossref","first-page":"e2541","DOI":"10.1371\/journal.pntd.0002541","article-title":"Severe South American ocular toxoplasmosis is associated with decreased ifn-\u03b3\/il-17a and increased il-6\/il-13 intraocular levels","volume":"7","author":"de-la-Torre","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.027_bib0019","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis nomenclature for reporting clinical data. Results of the First international workshop","volume":"140","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.02.027_bib0020","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","article-title":"A controlled retrospective study of Ganciclovir treatment for Cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome","volume":"107","author":"Holland","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2025.02.027_bib0021","unstructured":"World Health Organization. International Classification of Diseases 10 (ICD-10). 2006. https:\/\/www.who.int\/docs\/default-source\/classification\/icd\/official-updates\/icd10updates-2006.pdf?sfvrsn=107d47e6_2. Accesed January 12, 2024."},{"key":"10.1016\/j.ajo.2025.02.027_bib0022","series-title":"Diagnosis and Treatment of Uveitis","author":"Foster","year":"2013"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.027_bib0023","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0161-6420(02)00990-9","article-title":"Ocular toxoplasmosis: clinical features and prognosis of 154 patients","volume":"109","author":"Bosch-Driessen","year":"2002","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.027_bib0024","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12879-018-3613-8","article-title":"Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin","volume":"19","author":"de-la-Torre","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajo.2025.02.027_bib0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajo.2021.03.042","article-title":"Classification Criteria for toxoplasmic retinitis","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.027_bib0026","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3201\/eid1204.051081","article-title":"Recently acquired toxoplasma gondii infection, Brazil","volume":"12","author":"Jones","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.027_bib0027","first-page":"1","article-title":"Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management","volume":"137","author":"Holland","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.027_bib0028","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1442-9071.2009.02082.x","article-title":"Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia","volume":"37","author":"de-la-Torre","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.027_bib0029","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/eye.2008.219","article-title":"Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis","volume":"23","author":"de-la-Torre","year":"2009","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.027_bib0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/09286586.2020.1839509","article-title":"Clinical, socio-economic and environmental factors related with recurrences in ocular toxoplasmosis in Quind\u00edo, Colombia","volume":"28","author":"Velasco-Vel\u00e1squez","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.027_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004685","article-title":"Toxoplasmic retinochoroiditis: clinical characteristics and visual outcome in a prospective study","volume":"10","author":"Aleixo","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.027_bib0032","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/bjophthalmol-2014-305843","article-title":"Cuban ocular toxoplasmosis Epidemiology Study (COTES): incidence and prevalence of ocular toxoplasmosis in Central Cuba","volume":"99","author":"Bustillo","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.02.027_bib0033","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/09273948.2017.1367407","article-title":"Ocular toxoplasmosis in tropical areas: analysis and outcome of 190 patients from a multicenter collaborative study","volume":"26","author":"Huang","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.027_bib0034","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10792-007-9047-8","article-title":"Active ocular toxoplasmosis in Turkish patients: a report on 109 cases","volume":"26","author":"Tugal-Tutkun","year":"2007","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.027_bib0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10792-019-01242-1","article-title":"Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center","volume":"40","author":"Vishnevskia-Dai","year":"2020","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajo.2025.02.027_bib0036","unstructured":"G\u00f3mez-Mar\u00edn J.E., Ruiz B., Silva P., et al. Gu\u00eda de pr\u00e1ctica cl\u00ednica para toxoplasmosisdurante el embarazo y toxoplasmosis cong\u00e9nitaen Colombia. 2007. https:\/\/revistainfectio.org\/P_OJS\/index.php\/infectio\/article\/view\/148\/183"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.027_bib0037","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/archophthalmol.2009.354","article-title":"Outbreak of acquired ocular toxoplasmosis involving 248 patients","volume":"128","author":"Balasundaram","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"15","key":"10.1016\/j.ajo.2025.02.027_bib0038","doi-asserted-by":"crossref","first-page":"e0399","DOI":"10.1097\/MD.0000000000010399","article-title":"Patterns of ocular toxoplasmosis presenting at a tertiary eye care center in Korean patients","volume":"97","author":"Kim","year":"2018","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.027_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000449169","article-title":"Recent developments in the diagnosis and treatment of ocular toxoplasmosis","volume":"57","author":"Ozgonul","year":"2017","journal-title":"Ophthalmic Res"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.027_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(14)70986-9","article-title":"Eye manifestations of congenital toxoplasmosis","volume":"123","author":"Mets","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.027_bib0041","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpara.2013.09.007","article-title":"New clinical and experimental insights into Old World and neotropical ocular toxoplasmosis","volume":"44","author":"Pfaff","year":"2014","journal-title":"International Journal for Parasitology"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.027_bib0042","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/bjo.2002.013334","article-title":"The risk of complications of uveitis in a district hospital cohort","volume":"88","author":"Maini","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"7234","key":"10.1016\/j.ajo.2025.02.027_bib0043","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bmj.320.7234.555","article-title":"Regular review: management of chronic uveitis","volume":"320","author":"McCluskey","year":"2000","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.027_bib0044","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ophtha.2013.09.041","article-title":"Factors predictive of remission of new-onset anterior uveitis","volume":"121","author":"Artornsombudh","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.02.027_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273948.2016.1247174","article-title":"Complications of Uveitis: the Northern California Epidemiology of Uveitis Study","author":"Gritz","year":"2017","journal-title":"Ocular Immunology and Inflammation"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.027_bib0046","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ophtha.2013.09.023","article-title":"Incidence of visual improvement in Uveitis cases with visual impairment caused by macular edema","volume":"121","author":"Levin","year":"2014","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2025.02.027_bib0047","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.ophtha.2014.06.015","article-title":"Epidemiology of epiretinal membrane in a large cohort of patients with uveitis","volume":"121","author":"Nicholson","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.02.027_bib0048","article-title":"Prevalence and clinical characteristics of uveitic glaucoma: multicentric study in Bogot\u00e1, Colombia","author":"Rojas-Carabali","year":"2023","journal-title":"Eye"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:53:37Z","timestamp":1777694017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":48,"alternative-id":["S0002939425000923"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.02.027","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics Associated With Complications and Poor Visual Outcomes in Ocular Toxoplasmosis: Analysis of 853 Patients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}